Nephrolyx
PrivateLast Round
Seed
Dec 1, 2023
Total Funding Raised
$1.11M
Company Overview
Nephrolyx is a medical supplies company that develops and provides precise glomerular filtration rate (GFR) measurement solutions for clinical and research applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Clinical Trials, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware + Subscription, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nephrolyx Comparables
Compare Nephrolyx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Accunea Ltd | 78% | |
| MediBeacon | 76% | |
| numares Health | 71% |
Nephrolyx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 1, 2023 | ||||
| Seed | Jul 5, 2023 | ||||
| Accelerator | Oct 1, 2022 | ||||
| Accelerator | May 19, 2022 |
Key People
Founding team and executive leadership
Nephrolyx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IBB Ventures | Seed |
| German Accelerator | Accelerator |
| Creative Destruction Lab | Accelerator |
| European Regional Development Fund | Grant |
| Ascenion | Accelerator |
| State of Brandenburg | Grant |
| Business Angels Club Berlin-Brandenburg e.V. | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 29, 2024
Monthly visitors increased 176% MoM.
- Mar 3, 2024
Grew 38% QoQ, from 8 to 11 employees.
Nephrolyx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nephrolyx's valuation, stock price, and market status.
Is Nephrolyx a public or private company?
Nephrolyx is a private company.
What is the current stock price of Nephrolyx?
Nephrolyx is a private company with no public stock price. No recent secondary market data is available.
How much is Nephrolyx worth (valuation)?
Valuation information for Nephrolyx is not publicly available.
Can I buy Nephrolyx stock?
Nephrolyx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nephrolyx's last funding round?
Nephrolyx's most recent funding round was Seed on December 1, 2023.
Who are the main investors in Nephrolyx?
Key investors in Nephrolyx include High-Tech Gründerfonds.
Will Nephrolyx IPO soon?
No public IPO plans have been announced for Nephrolyx.
How can I track Nephrolyx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nephrolyx's secondary market activity and sign up for updates.